SCHEMBL8552701

SCHEMBL8552701

CN1CCC(NCC(O)COc2ccc(F)cc2)CC1

nearest known ligand 0.73

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.67
CYP2D6 P10635 1/20 0.67
ADRB1 P08588 5/20 0.63
ADRB3 P13945 5/20 0.63
ADRB2 P07550 4/20 0.63
HTR2A P28223 1/20 0.55
TSHR P16473 1/20 0.54
LMNA P02545 3/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
SSTR4 P31391 1/20 0.52
ALDH1A1 P00352 1/20 0.52
MAPT P10636 1/20 0.52
HTT P42858 1/20 0.52
ATF4 P18848 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25053044 0.87 ADRB1 (0.69) CYP3A4CYP2D6ADRB1ADRB3ADRB2
SCHEMBL20883370 0.77 TSHR (0.69) CYP3A4CYP2D6TSHRLMNAMEN1
SCHEMBL20883491 0.76 LMNA (0.64) CYP3A4CYP2D6ADRB1ADRB3ADRB2
SCHEMBL8553914 0.75 USP2 (0.58) CYP2D6HTR2ALMNAMEN1KMT2A
SCHEMBL22545051 0.75 ADRB1 (0.55) CYP3A4CYP2D6ADRB1ADRB3ADRB2
SCHEMBL7808692 0.75 TSHR (0.75) CYP2D6TSHRMEN1KMT2AMAPT
SCHEMBL22640024 0.75 MEN1 (0.70) ADRB2LMNAMEN1KMT2AALDH1A1
SCHEMBL22640079 0.75 MEN1 (0.70) ADRB2LMNAMEN1KMT2AALDH1A1
SCHEMBL20877004 0.75 ADRB3 (0.60) CYP3A4CYP2D6ADRB1ADRB3ADRB2
SCHEMBL20854550 0.74 KCNH2 (0.62) TSHRLMNAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0842174-A1 HETEROCYCLIC COMPOUNDS FOR TREATING MYOCARDIAL ISCHAEMIA PIERRE FABRE MEDICAMENT (FR) 1998-05-20 EP disclosed
WO-1997005134-A1 HETEROCYCLIC COMPOUNDS FOR TREATING MYOCARDIAL ISCHAEMIA PIERRE FABRE MEDICAMENT (FR) 1997-02-13 WO disclosed